Welcome to Hypothesize That!, the UCB science podcast where science meets conjecture and curiosity, and the biggest ‘What If’s’ come to life. Join host Nicola Hill as she delves into the most provocative trends, theories, and questions shaping the future of discovery and development with top scientists, industry leaders, and patient advocates. From the transformative power of AI and virtual labs to the rise of decentralized clinical trials and patient-centred gene therapies, each episode tackles the biggest questions shaping pharma's future.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>

Hypothesize That!
Claim This Podcastby UCB Biopharma
Podcast Overview
Welcome to Hypothesize That!, the UCB science podcast where science meets conjecture and curiosity, and the biggest ‘What If’s’ come to life. Join host Nicola Hill as she delves into the most provocative trends, theories, and questions shaping the future of discovery and development with top scientists, industry leaders, and patient advocates. From the transformative power of AI and virtual labs to the rise of decentralized clinical trials and patient-centred gene therapies, each episode tackles the biggest questions shaping pharma's future.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
Language
🇺🇲
Publishing Since
4/14/2025
1 verified contact email on file for Hypothesize That!
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes

April 29, 2026
Episode 4: Smart drugs, dumb trials: rethinking the foundations of drug development
<p> </p><p>In this episode, host Nicola Hill, is joined by Professor Maddie Parsons, Dean of Research Excellence Frameworks at King’s College London, and Dr Graham Price, Head of Global Clinical Development at UCB, to examine whether today’s trials are fit for tomorrow’s science.</p><p> </p><p>Listen to our guests unpick the tensions in modern drug development from conservative endpoints, missed opportunities and lack of integration across clinical and scientific disciplines. Can smarter design, better data sharing, and deeper collaboration unlock the future of precision medicine?</p><p> </p><p>This podcast is produced and funded by UCB.</p><p> </p><p>Hosted on Acast. See <a href="https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Facast.com%2Fprivacy&data=05%7C02%7Cpolly%40broadcastrevolution.co.uk%7C55232ab589fc485246dd08dea510a598%7Cee4bcdbbdf2c4475aa14f299fd60aaaf%7C0%7C0%7C639129688127370872%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=108%2BIA3rptKr4WdkzcW6CfedFyCYhw6Oag4DjYR6SdQ%3D&reserved=0" rel="noopener noreferrer" target="_blank"><u>acast.com/privacy</u></a> for more information.</p><p><strong> </strong></p><p>GL-OT-2600003 – March 2026</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>

April 29, 2026
Episode 4 (BONUS): Crimes Against Innovation: Secrecy in Science vs. Risk Adverse Funding
<p>Deep in the shadowy corridors of laboratories and the silent pages of medical journals, progress can falter, not for lack of brilliance, but because of the systems surrounding it. Ideas are delayed, discoveries are hidden, and bold thinking is quietly discouraged. This is Crimes Against Innovation.</p><p><strong> </strong></p><p>Join Professor Maddie Parsons and Dr Graham Price as they go head-to-head on two major offenders in healthcare innovation. Maddie argues that playing it safe and avoiding high-risk research is suppressing transformative breakthroughs, while Graham challenges that the bigger crime is secrecy in science - a true assassin of progress.</p><p> </p><p>Host Nicola Hill weighs the evidence and delivers the verdict on which of these “crimes” does the greatest damage to discovery.</p><br><p>This podcast is produced and funded by UCB.</p><p> </p><p>Hosted on Acast. See <a href="https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Facast.com%2Fprivacy&data=05%7C02%7Cpolly%40broadcastrevolution.co.uk%7C05e28195313a42845e8408dea553dc91%7Cee4bcdbbdf2c4475aa14f299fd60aaaf%7C0%7C0%7C639129976839443374%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=pZcilMMLS7brtD%2B5Kugi8OhVTTEY2LEElzrBx%2BTqnzw%3D&reserved=0" rel="noopener noreferrer" target="_blank"><u>acast.com/privacy</u></a> for more information.</p><p> </p><p>This podcast is produced and funded by UCB.</p><p><strong> </strong></p><p>GL-OT-2600003 – March 2026</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>

August 4, 2025
Episode 3: Gene Therapy’s Future: Will Patient Engagement Eclipse Science?
<p>Is scientific innovation enough to drive the future of gene therapy, or is patient engagement the missing key? Join host Nicola Hill as she explores this question with Laurence Woollard, a rare disease advocate, and UCB’s Global Patient Engagement Lead, Dr. Emma Lane. Together, they discuss the critical role of patients in co-creating therapies that meet real-world needs, the ethical challenges of gene editing, and how early collaboration can build trust and transparency. Hear real-world insights into how patient voices are reshaping R&D—and how industry can embrace this paradigm shift.</p><p> </p><p> </p><p>This podcast is produced and funded by UCB.</p><p>Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer" target="_blank">acast.com/privacy</a> for more information.</p><br><p>IE-OT-2500003 – July 2025</p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
9 total episodes available
Deep-dive analytics for Hypothesize That!
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Hypothesize That!?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Information about guest appearances is not available.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.
